HHS CDC - Strengthening Lyme Disease Surveillance & Research - MRAS

The Department of Health and Human Services (HHS), in collaboration with the General Services Administration (GSA), is undertaking a market research initiative to enhance Lyme disease surveillance and research. This effort is part of a broader goal to improve public health responses and outcomes related to Lyme disease, which has become an increasing concern in many parts of the United States. The GSA is facilitating this process by gathering information on capabilities and innovative solutions from potential contractors through a structured Request for Information (RFI) process.

The work being requested involves comprehensive support for strengthening the surveillance systems that monitor Lyme disease cases, as well as advancing research efforts to better understand the disease's epidemiology, transmission, and impact. This may include developing new data collection methodologies, enhancing existing databases, and integrating advanced analytics tools to identify trends and inform public health strategies. The ultimate aim is to provide HHS with actionable insights that can guide policy decisions and resource allocation for more effective management of Lyme disease.

Additionally, there is an emphasis on leveraging technology to improve data accuracy and accessibility. Contractors are expected to propose solutions that incorporate cutting-edge technologies such as machine learning algorithms or geographic information systems (GIS) for mapping disease spread patterns. These innovations should facilitate real-time reporting and enable quicker responses from health authorities.